Compounding Drug Pricing Pharmaceutical Manufacturing 
Pharmacy Times
JUNE 23, 2025
This pathway’s expanded use and shifting Centers for Medicare & Medicaid Services (CMS) policies are reshaping reimbursement practices and therapeutic equivalence standards for 505(b)(2) drugs. It is basically an essential copy, and the pharmaceutical manufacturer has to show bioequivalence to the reference product,” Soefje said. “If
Putting Patients First Blog
MAY 6, 2025
4 ,5 Millions of Americans rely on medicines that are manufactured outside the United States, particularly from close and longstanding allies such as Ireland, Switzerland, and the United Kingdomcountries whose regulatory frameworks for pharmaceutical manufacturing mirror the high standards enforced domestically.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 16, 2025
According to Trump, patients could see cost reductions of 30% to 80%, but experts question the feasibility and practicality of implementing such a policy within the complex United States drug pricing and supply system. Kennedy Jr, is permitted to develop a new rule that ties American drug prices to those of other nations.
PharmaTech
AUGUST 1, 2025
The industry's dependence on geopolitical stability and predictable trade relationships is increasingly critical for global pharmaceutical manufacturing. Regulatory complexities and inconsistent enforcement further compound these challenges, complicating long-term planning for compliance, cost forecasting, and sourcing.
Pharmaceutical Commerce
JULY 31, 2025
Tariffs on China will make generic drug prices go up I assume because China is such an important supplier of active pharmaceutical ingredients, as well as finished products.” 18 – The US announces it plans to improve a tariff of 25% or higher on pharmaceuticals. Pharmaceutical Commerce. Pharmaceutical Commerce.
Pharmacy Times
JUNE 12, 2025
Trump signed an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” with the objective of lowering drug prices, namely on branded drug products, for American consumers. How Does Drug Pricing in the US Compare With Other Countries? REFERENCES 1.
Pharmacy Times
AUGUST 5, 2025
2 Although seen as restoring incentives for rare disease research, critics argue it perpetuates high pricing and industry-friendly policy. The OBBB expanded the list of drugs exempt from negotiation and delayed implementation of new price controls.
Expert insights. Personalized for you.
Let's personalize your content